Neoadjuvant chemoradiation and intraoperative electron irradiation for locally unresectable/borderline resectable pancreas adenocarcinoma

被引：1
作者：
Ben Ashman, Jonathan [1 ]
Moss, Adyr A. [1 ]
Callister, Matthew D. [1 ]
Reddy, Kunam S. [1 ]
Mulligan, David C. [1 ]
Gunderson, Leonard L. [1 ]
Borad, Mitesh J. [1 ]
机构：
[1] Mayo Clin, Scottsdale, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.327
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
327
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Intraoperative Radiotherapy after Neoadjuvant Chemotherapy and Radiotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma: A Single-Institution Analysis
    Sadek, Kareem
    Tice, Mary P.
    Poruk, Katherine E.
    Stauffer, John A.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S283 - S284
  • [42] Institutional experience in induction chemotherapy and neoadjuvant IMRT for borderline resectable and locally advanced pancreatic adenocarcinoma
    de Torres Olombrada, M. V.
    Garcia Canibano, T.
    Juez Martel, I.
    Gutierrez Abad, D.
    Pereira Perez, F.
    Ludena Martinez, B.
    ANNALS OF ONCOLOGY, 2015, 26
  • [43] Patterns of Local Failure after Neoadjuvant Radiation For Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
    Rhieu, B. H.
    Han-Oh, S.
    Guss, Z. D.
    Cheng, Z.
    Meyer, J. J.
    Herman, J. M.
    Narang, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E243 - E243
  • [44] Outcomes with FOLFIRINOX for borderline resectable and locally unresectable pancreatic cancer
    Boone, Brian A.
    Steve, Jennifer
    Krasinskas, Alyssa M.
    Zureikat, Amer H.
    Lembersky, Barry C.
    Gibson, Michael K.
    Stoller, Ronald G.
    Zeh, Herbert J.
    Bahary, Nathan
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 108 (04) : 236 - 241
  • [45] Gemcitabine-Based Chemoradiotherapy Followed by Surgery for Borderline Resectable and Locally Unresectable Pancreatic Ductal Adenocarcinoma
    Kobayashi, Motoyuki
    Mizuno, Shugo
    Murata, Yasuhiro
    Kishiwada, Masashi
    Usui, Masanobu
    Sakurai, Hiroyuki
    Tabata, Masami
    Ii, Noriko
    Yamakado, Koichiro
    Inoue, Hiroyuki
    Shiraishi, Taizo
    Yamada, Tomomi
    Isaji, Shuji
    PANCREAS, 2014, 43 (03) : 350 - 360
  • [46] Efficacy of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma
    Kang, J.
    Kim, K-P.
    Yoo, C.
    Lee, J-L.
    Ryoo, B-Y.
    Chang, H-M.
    Lee, S. S.
    Park, D. H.
    Song, T. J.
    Seo, D. W.
    Lee, S. K.
    Kim, M-H.
    Hwang, D. W.
    Song, K. B.
    Lee, J. H.
    Kim, S. C.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    R. Álvarez
    I. Alés
    R. Díaz
    B. G. de Paredes
    M. Hidalgo
    Clinical and Translational Oncology, 2017, 19 : 1193 - 1198
  • [48] Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Kaufmann, Benedikt
    Hartmann, Daniel
    D'Haese, Jan G.
    Stupakov, Pavel
    Radenkovic, Dejan
    Gloor, Beat
    Friess, Helmut
    DIGESTIVE SURGERY, 2019, 36 (06) : 455 - 461
  • [49] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10) : 1193 - 1198
  • [50] Neoadjuvant nab-paclitaxel and gemcitabine (AG) in borderline resectable (BR) or unresectable (UR) locally advanced pancreatic adenocarcinoma (LAPC) in patients ineligible for FOLFIRINOX
    Peterson, Shawn
    Loaiza-Bonilla, Arturo
    Ben-Josef, Edgar
    Drebin, Jeffrey A.
    Westendorf-Overley, Colleen
    Anthony, Lowell Brian
    DeSimone, Philip A.
    Goel, Gaurav
    Kudrimoti, Mahesh R.
    Dineen, Sean Patrick
    Tzeng, Ching-Wei David
    Hosein, Peter J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345